Matthew Sykes

9PUBLICATIONS
20CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designPredictive and prognostic markersBiologically active moleculesReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 23, 2023
Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis.

Jack L Janetzki, Matthew J Sykes, Michael B Ward

|Oct 27, 2023
Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in <i>Escherichia coli</i>.

Lily A Pisoni, Susan J Semple, Sida Liu

|May 12, 2023
Application of an Integrative Drug Safety Model for Detection of Adverse Drug Events Associated With Inhibition of Glutathione Peroxidase 1 in Chronic Obstructive Pulmonary Disease.

Jack L Janetzki, Nicole L Pratt, Michael B Ward

|Apr 13, 2023
Discovery of <i>N</i>,4-Di(1<i>H</i>-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation.

Biruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo

|Jul 27, 2022
Therapeutic Potential of a Novel Vitamin D<sub>3</sub> Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding.

Ali K Alshabrawy, Yingjie Cui, Cyan Sylvester

|Mar 21, 2022
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.

Mingfeng Yu, Yuchao Yang, Matthew Sykes

Pageof 2

Frequent Collaborators

4 joint publications

Michael Ward

3 joint publications

Shudong Wang

3 joint publications

Jack L Janetzki

3 joint publications

Nicole L Pratt